First Eagle Investment Management, LLC Cue Biopharma, Inc. Transaction History

First Eagle Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$7.91 - $11.89 $1.54 Million - $2.32 Million	-195,000 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$10.93 - $14.48 $3.33 Million - $4.42 Million	-305,000 Reduced 61.0%	195,000 $2.31 Million
Q1 2018 May 04, 2018	BUY	$11.63 - $17.25 $5.82 Million - $8.63 Million	500,000 New	500,000 $7.03 Million

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.